QA: ABBOTT LABORATORIES in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000001800_2022_ABBOTT_LABORATORIES.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000001800, ABBOTT LABORATORIES

  xvar xval
0 AssetsCurrent 24,239,000,000
1 IntangibleAssetsNetIncludingGoodwill 35,970,000,000
2 PropertyPlantAndEquipmentNet 8,959,000,000
3 remainder_Assets 6,028,000,000
4 LiabilitiesCurrent 13,105,000,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 18,537,000,000
8 SellingGeneralAndAdministrativeExpense 11,324,000,000
9 ResearchAndDevelopmentExpense 2,742,000,000
10 remainder_Expenses 3,720,000,000
11 remainder_Revenues 43,075,000,000
12 remainder_NetIncome 319,000,000
13 remainder_ComprehensiveNetIncome 572,000,000
  yvar yval
0 Assets 75,196,000,000
1 Liabilities 13,105,000,000
2 Expenses 36,323,000,000
3 Revenues 43,075,000,000
4 StockholdersEquity 62,091,000,000
5 NetIncome 7,071,000,000
6 ComprehensiveNetIncome 7,357,000,000
7 BaseVar 84,295,000,000
8 EconomicCapitalRatio 2.59

Edgar->Model Mapping

Feature Distribution

Change over Time